|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Endometriosis | |||||
| Infertility | |||||
| 2 | More general conditions related to this trial | ||||
| Genital Diseases, Female | |||||
| Genital Diseases, Male | |||||
| 3 | Interventions listed in this trial | ||||
| Leuprolide acetate | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Leuprolide | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Fertility Agents | |||||
| Fertility Agents, Female | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Colorado Center for Reproductive Medicine | |||||